Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Faster-acting insulin aspart vs NovoRapid in combination with insulin degludec in adults with type 1 diabetes
2015-001047-36Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Sep 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of human insulin in diabetes mellitus type 1 (T1D), sponsored by Novo Nordisk. Started Sep 2015; status: completed.
02
Drugs
human insulin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2015-001047-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001047-36.